My Account Cart Contents Proceed to Checkout
 


Quick Find
 
 
Use keywords to find the product you are looking for.
Advanced Search
 
 
E-Newsletter
 
Sign up for biosensis Product Features
 
 
Adjukine B: new generation of Adjuvants

$210.00USD

Catalogue No.: A-001-100
Batch No.: See product label
Unit size: 100 µl freeze-dried (concentrated)
Description: Adjukine is a generic name for a new generation of potent adjuvants designed to allow a better control over the immune response in mammals upon immunization. The immune response against antigens initiates and evolves amid a complex, yet highly regulated sequence of events. This is only possible by a well coordinated interaction among different cell types via synthesis and secretion of a wide range of cytokines, inflammatory molecules and through cell-cell contact. The outcome of the immune response varies depending on factors including type, form, quantity and route of the administration of the antigen. Adjukine B is an adjuvant formulation designed to facilitate an antigen specific immune response, by recreating, at the site of immunization, the optimal conditions for the immune-competent cells to coordinate a potent B cell response, leading to a strong production of high affinity antibodies. Adjukine B is particularly useful to break immunotolerance against autoantigens or highly conserved proteins. It is also strongly recommended when using low immunogenic antigens such as peptides.
Biol. activity: Stimulates strong antibody response upon antigen challenge.
Applications: Boost of immune response upon antigen challenge, antibody production. 500 µl per rabbit is recommended.
Form: Lyophilised
Reconstitution: Reconstitute/dilute by adding 1000 µl of sterile PBS and gently mix. Avoid foam formation.
Storage: Keep at -20ºC until use. The reconstituted Adjukine B may be kept at -20ºC.
References: 1. Partidos C D et al. Vaccine. 2004 Jun 23;22(19):2385-90.
2. Hu J et al. Vaccine. 2004 Mar 12;22(9-10):1124-30.
3. Cornelie S et al. Scand J Immunol. 2004 Feb;59(2):143-51.
4. Provinciali M et al. Mech Ageing Dev. 1994 Dec 16;77(2):75-82.
5. Daynes RA et al. Ann N Y Acad Sci. 1994 Aug 15;730:144-61.
6. Freund J. Am J Clin Pathol. 1951 Jul;21(7):645-56.
Images
Adjukine B: new generation of Adjuvants Adjukine B Administration. (1) Immunise the animal with your immunogen as you normally do (A). (2) Using an insulin syringe, inject 500 µl of the reconstituted Adjukine B in at least three different places around one of the injection sites (B).  It is recommended that  Adjukine B be injected together with the first injection using FCA (Freund's Complete Adjuvant). Do not include Adjukine B in the antigen emulsion.

PDF Data Sheet

Click to download the data sheet - Click to download the Data Sheet

MSDS

Click to download the data sheet - Click to download the Material Safety Data Sheet

Available Options:
Host Species:
Reviews
My Esky  Click to visit My Esky
 
0 items
 
 
Currencies
 
  
 
 
Email This Page
 
 
Tell someone you know about this product.
 
 
Notifications  Click to visit Notifications
 
Notify me of updates to Adjukine B: new generation of Adjuvants
 
 
We Accept PayPal
 
You can use secured services of paypal to send us money via our email account webpay@biosensis.comYou can use secured services of paypal to send us money via our email account webpay@biosensis.comYou can use secured services of paypal to send us money via our email account webpay@biosensis.com
Click to make a payment


Official PayPal Seal
 
 
Reviews  Click to visit Reviews
 
Write a review on this product!